Link to the video campaign: https://www.youtube.com/watch?v=Oe2hOqlWXJs

The sobering reality in India is that for every 10 lakh Indians, less than 1% pledge to donate their organs to those in need. This significant gap between demand and supply has resulted in thousands of patients waiting for life-saving organ transplants, including kidneys, liver, eyes, and hearts.

Rajeev Juneja, Vice-Chairman and Managing Director, Mankind Pharma shared, “At Mankind Pharma, we believe that collective action has the power to transform healthcare outcomes. Our organ donation awareness campaign reflects our steadfast commitment to tackling one of India’s most pressing health challenges. Registering as an organ donor is a simple step, yet it holds the power to change and even save multiple lives. By this initiative, we aim to engage with our wider community and honour the compassionate individuals who choose to give the ultimate gift of life. We call upon every Indian to take this pledge and be part of a legacy that continues long after our time.”

On this initiative by Mankind, Dr Kanika Rastogi, Deputy Director – National Organ and Tissue Transplant Organization (NOTTO) commented, “India’s low organ donation rate has left thousands of patients waiting for a second chance at life. This campaign by Mankind Pharma is an important step in addressing this shortage. By creating awareness and simplifying the process of registration, we can inspire more people to pledge. Just one donor has the power to save up to eight lives, a gift of hope that truly extends beyond our own.”

Medical experts – Dr. A.K. Bhalla (Sir Ganga Ram Hospital) and Dr. Neelam Mohan (Medanta) – addressed the humanitarian importance of organ donation, dispelled myths and highlighted the vast demand-supply gap in organ availability. They lauded Mankind Pharma’s campaign and reiterated that such social awareness initiatives are vital to spreading the message on the need to donate organs.

The video campaign featuring Amitabh Bachchan serves as a clarion call to the nation, urging Indians to make an invaluable promise that can save the lives of many. By leveraging the megastar’s influential voice and Mankind Pharma’s commitment to healthcare advancement, the initiative seeks to create a lasting impact on public consciousness about the importance of organ donation.

This World Organ Donation Day, Mankind Pharma calls upon every Indian to consider the profound impact they can have on society by taking the simple yet meaningful step of registering as an organ donor. The campaign reinforces that the legacy of giving extends far beyond one’s lifetime, creating ripples of hope and healing for generations to come.

The post World Organ Donation Day: Mankind Pharma Launches Video Campaign Featuring Amitabh Bachchan to Drive Organ Donation Awareness appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

Written by: – Dr. Pradeep V. Mahajan

MBBS, MS (General Surgery), DU (Urology, Austria), AFIH (Associate Fellow of Industrial Health, (Government of India),

Diplomat – American Board of Regenerative Medicine (ABRM)

In the realm of medical science, the act of organ donation is often equated with the divine gift of life itself. It’s a profound gesture of compassion, one that transcends boundaries and brings hope to countless individuals facing the direst of circumstances. However, despite tremendous advancements in medical technology, the challenges of organ rejection and the limited availability of organs have remained stubbornly unanswered for the past seven decades since the groundbreaking renal transplant of 1954 in Boston.

Yet, hope continues to spring eternal in the field of regenerative medicine. StemRx, a pioneering organization at the forefront of biomedical innovation, is poised to revolutionize the landscape of organ transplantation. Through a multifaceted approach that encompasses cutting-edge technologies like 3D bioprinting, cell transplantation, and, most notably, decellularization, StemRx is taking a giant leap toward solving the organ shortage crisis.

Decellularization, a remarkable process gaining prominence in the field, is now being harnessed by StemRx to manufacture organs within the confines of a laboratory. In this quest to gift life, researchers worldwide are leaving no stone unturned, aiming to develop organs that could one day serve as readily available replacements for those in need.

One such promising endeavor involves the decellularization of porcine hearts. This approach could potentially offer a blueprint for the future creation of human organs. The process is intricate yet fascinating, involving the complete removal of cellular components from the porcine heart while preserving the vital extracellular matrix (ECM) structure. This decellularized ECM serves as a three-dimensional template that could be recellularized with either human cardiomyocytes or endothelial cells, rendering it suitable for organ transplantation, disease modeling, and drug discovery.

The Decellularization Process:

The heart of this revolutionary endeavor lies in the method of decellularization. Porcine hearts are chosen for their similarity to the human heart, making them excellent candidates for study and experimentation. The process begins with perfusion, a technique that involves circulating a specialized solution containing detergents, enzymes, and other agents through the heart’s vasculature.

Picture this: a porcine heart, once vibrant with life, now suspended in a sterile laboratory environment. Tubes and catheters intricately connected to the heart’s arteries and veins ensure the efficient distribution of the decellularization solution. This solution effectively washes away the cellular components of the heart, leaving behind an intricate scaffolding – the ECM structure.

What remains is a ghostly, translucent framework of the original heart, devoid of cells but retaining the intricate architecture that allows the heart to function. This decellularized heart serves as a remarkable 3D template, ready to be populated with the life-giving cells required for it to beat once more.

The Promise of Decellularization:

The potential of decellularization is nothing short of extraordinary. These decellularized organs can be reseeded with either porcine myocardial cells or endothelial cells, creating pulsating hearts in the controlled environment of a laboratory. These hearts, while not suitable for immediate transplantation into humans, serve as invaluable tools for research, testing, and development.

Decellularized organs open up new avenues for understanding heart biology, drug testing, and even personalized medicine. They can be used to study disease progression, screen potential medications, and investigate novel treatment approaches. Furthermore, they provide a stepping stone toward the ultimate goal: bioengineered human organs that can address the perpetual shortage of transplantable hearts and save countless lives.

In conclusion, the science of gifting organs is indeed the science of gifting life itself, akin to a divine act of benevolence. StemRx’s pioneering work in the field of decellularization, as exemplified by their work with porcine hearts, holds the promise of reshaping the future of organ transplantation. Through meticulous research and innovative technologies, we inch closer to a world where the gift of an organ can truly be equated with the gift of God – a gift that offers hope, healing, and the opportunity for a new lease on life.

Before Decellularization

After Decellularization

The post Title: The Gift of the Organ is Equivalent to the Gift of Life appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.